Pharmalot

By  Ed Silverman

Taking stock of the drug industry, from the lab to the medicine chest. Sign up for the newsletter here.

Pharmalot

Pharmalittle: D.C. law firms prep pharma for a Democratic house; Allergan loses another battle over Restasis patent deal

By Ed Silverman

Pharmalot

Mallinckrodt will be honored for research into a drug that causes sticker shock

By Ed Silverman

Pharmalot

Pharmalittle: Pharma ‘war games’ for a Trump-Democrat alliance on drug prices; Arizona ends vaccine education program

By Ed Silverman

Pharmalot

Maryland attorney general asks Supreme Court to uphold generic price gouging law

By Ed Silverman

Cancer Drugs
Pharmalot

Some European countries decide to cover cancer drugs much faster than others

By Ed Silverman

Pharmalot

Former J&J employee claims she was fired for blowing the whistle on vision care group

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Europe is set to approve the Sanofi dengue vaccine; FDA panel chair disses panel vote

By Ed Silverman

FDA campus
Pharmalot

An FDA expert panel chairman defies his own panel for endorsing an opioid painkiller

By Ed Silverman

A photo of Hydrocodone Acetaminophen.
Pharmalot

Cardinal Health faces pressure to rework executive pay to reflect any opioid settlements

By Ed Silverman

Pharmalot

Pharmalittle: Pfizer offers early retirement ahead of layoffs; Novartis buys Endocyte for $2.1 billion

By Ed Silverman

Astellas Suspended
Pharmalot

FDA scolds Eisai after a rep makes off-label statements to doctors

By Ed Silverman

Truvada/PReP
Pharmalot

Gilead’s HIV prevention pill can greatly reduce new infections in targeted rollouts

By Ed Silverman

Pharmalot

Abbott sues a former product manager over concerns a rival has trade secrets

By Ed Silverman

Pharmalot

Pharmalittle: Teva faces setback in new migraine drug market; prices for valsartan jump in the U.S.

By Ed Silverman

Insulin NOVO NORDISK
Pharmalot

Minnesota becomes first state to sue major insulin makers over price-gouging

By Ed Silverman

Pharmalot
Pharmalot

U.S. antitrust regulators are investigating a key supplier of radiology medicines

By Ed Silverman

Pharmalot

Pharmalittle: Legal issues loom over disclosing prices in TV ads; AstraZeneca halts U.K. investment over Brexit worries

By Ed Silverman

PBM pharmacy pill costs
Pharmalot

A cost-effectiveness watchdog may charge drug makers for ‘early scientific advice’

By Ed Silverman

NEJM Dengue Vaccine
Pharmalot

Controversy over a Sanofi dengue vaccine caused a crisis of confidence in the Philippines

By Ed Silverman

Pharmalot

Pharmalittle: Trump to require drug prices in ads; Europe cracks down on valsartan ingredients maker

By Ed Silverman

Diabetes Transplants
Pharmalot

Merck scraps plans to sell a biosimilar version of Lantus as the insulin market gets crowded

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: FDA approves a record number of generics; Bristol-Myers’ Opdivo fails lung cancer study goal

By Ed Silverman

Cancer Research Cells
Pharmalot

Industry influence over clinical trial design and reporting lacks transparency

By Ed Silverman

Pharmalot

Pfizer pays $700,000 to settle charges over misleading copay coupons

By Ed Silverman

Pharmalot

Pharmalittle: Azar promises more action on drug costs; Trump flubs explanation of ‘gag clause’ law

By Ed Silverman

Pill Dollars
Pharmalot

Surprise, surprise: Price hikes contributed a lot to sales growth for the biggest-selling drugs

By Ed Silverman

Utility pole
Pharmalot

A growing number of states consider legislation to treat pharma as a utility

By Ed Silverman

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy